- Blog
- News & Media
- Issues
- About The Biopharmaceutical Sector
- Access and Affordability
- Adherence
- Appropriate Use Of Medicines
- Counterfeit Drugs
- Disaster Response
- Drug Safety
- Environmental Issues
- Food And Drug Administration
- Importation
- Intellectual Property
- International
- Medical Advances
- Medicare
- Prescription Drug Abuse
- Prescription Drug User Fee Act
- Sales And Marketing
- Research
- About
The Biopharmaceutical Sector’s Impact on the Economy of Hawaii
This fact sheet presents an analysis of the impact of the biopharmaceutical sector on the economy of Hawaii (HI) in 2008, including data on employment, economic output, and research and development activity. The biopharmaceutical sector’s economic impact includes not only the direct impact of its companies, but also the ripple effects that the sector has throughout the rest of the economy. These ripple effects include both the indirect impact, the economic value of the goods or services used to support biopharmaceutical companies, and the induced impact, the value of the economic activity supported by the spending of the direct and indirect employees of the biopharmaceutical sector.
Additional Information on the Biopharmaceutical Sector’s Impact in Hawaii:
PhRMA commissioned Battelle to conduct this study to examine the extent to which state governments are targeting the industry for economic growth and development:
- Hawaii is focusing on encouraging innovation to grow the state’s technology sector, including its life sciences industry
- The state has made significant investments in the University of Hawaii’s John A. Burns School of Medicine, including building a new campus on the island of Oahu intended to anchor a bioscience park
- The primary way in which Hawaii has tried to stimulate the development of the state’s technology-based industries is by offering tax credits designed to increase the capital available to technology-based start-up
*Battelle state fact sheets use the latest data available at the time of publication. This may predate the data from the Archstone reports, which use 2008 data.
